{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:48:29Z","timestamp":1789541309988,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11033-020-06056-4","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T12:04:42Z","timestamp":1607515482000},"page":"843-854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-9091","authenticated-orcid":false,"given":"Rob\u00e9rio Amorim","family":"de Almeida Pond\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"6056_CR1","unstructured":"World Health Organization (2017) Global Hepatitis Report (2017) WHO, Geneva. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665 \/25501 6\/97892 41565 455-eng.pdf;jsessionid=E755A 57371 4A211 D864D 6FECC 4B18D 47?sequence=1"},{"issue":"1","key":"6056_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","volume":"67","author":"S Schillie","year":"2018","unstructured":"Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP (2018) Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 67(1):1\u201331. https:\/\/doi.org\/10.15585\/mmwr.rr6701a1","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"6056_CR3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jhin.2006.06.029","volume":"64","author":"K Kidd-Ljunggren","year":"2006","unstructured":"Kidd-Ljunggren K, Holmberg A, Bl\u00e4ckberg J, Lindqvist B (2006) High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect 64(4):352\u2013357","journal-title":"J Hosp Infect"},{"issue":"6","key":"6056_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12072-017-9831-0","volume":"11","author":"YF Shih","year":"2017","unstructured":"Shih YF, Liu CJ (2017) Mother-to-infant transmission of hepatitis B virus: challenges and perspectives. Hepatol Int 11(6):481\u2013484","journal-title":"Hepatol Int"},{"key":"6056_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7262.2006.00141.x","volume":"8","author":"BA Ali","year":"2006","unstructured":"Ali BA, Huang TH, Salem HH, Xie QD (2006) Expression of hepatitis B virus genes in early embryonic cells originated from hamster ova and human spermatozoa transfected with the complete viral genome. Asian J Androl 8:273\u2013279","journal-title":"Asian J Androl"},{"issue":"2","key":"6056_CR6","first-page":"4651","volume":"4","author":"LH Cao","year":"2015","unstructured":"Cao LH, Liu ZM, Zhao PL, Sun SC, Xu DB, Shao MH, Zhang JD (2015) Efficacy of combined hepatitis B immunoglobulin and hepatitis B vaccine in blocking father-infant transmission of hepatitis B viral infection. Genet Mol Res 4(2):4651\u20134657","journal-title":"Genet Mol Res"},{"issue":"6","key":"6056_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","volume":"4","author":"G Indolfi","year":"2019","unstructured":"Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, Bulterys M, Chan PL, El-Sayed MH, Giaquinto C, Jonas MM, Meyers T, Walsh N, Wirth S, Penazzato M (2019) Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol 4(6):466\u2013476. https:\/\/doi.org\/10.1016\/S2468-1253(19)30042-1 Erratum in: Lancet Gastroenterol Hepatol. 2020 May;5(5):e4. PMID: 30982722","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"6056_CR8","unstructured":"Busch M (2001) HBV viremia preceding HBsAg positivity: implications for MP and ID HBV NAT. Presented at the US FDA Blood Products Advisory Commitee meeting, Gaithersburg, MD, March 15"},{"key":"6056_CR9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1537-2995.2003.00424.x","volume":"43","author":"R Biswas","year":"2003","unstructured":"Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW (2003) Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 43:788\u2013798","journal-title":"Transfusion"},{"issue":"2","key":"6056_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1423-0410.2005.00602.x","volume":"88","author":"A Yoshikawa","year":"2005","unstructured":"Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, Japanese Red Cross NAT Screening Research Group (2005) HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 88(2):77\u201386","journal-title":"Vox Sang"},{"issue":"1258","key":"6056_CR11","first-page":"66","volume":"45","author":"MH Koppelman","year":"2005","unstructured":"Koppelman MH, Assal A, Chudy M et al (2005) Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 45(1258):66","journal-title":"Transfusion"},{"issue":"Suppl. 1","key":"6056_CR12","first-page":"30","volume":"36","author":"FT Chyang","year":"2006","unstructured":"Chyang FT (2006) Blood screening for HBV DNA. J Clin Virol 36(Suppl. 1):30\u201332","journal-title":"J Clin Virol"},{"key":"6056_CR13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","volume":"334","author":"GB Schreiber","year":"1996","unstructured":"Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. N Engl J Med 334:1685\u20131690","journal-title":"N Engl J Med"},{"key":"6056_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-3148.2002.00382.x","volume":"12","author":"P Grant","year":"2002","unstructured":"Grant P, Busch M (2002) Nucleic acid amplification technology methods used in blood donor screening. Transfus Med 12:229\u2013242","journal-title":"Transfus Med"},{"issue":"Suppl 1","key":"6056_CR15","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1386-6532(06)80005-3","volume":"36","author":"SH Kleinman","year":"2006","unstructured":"Kleinman SH, Busch MP (2006) Assessing the impact of HBV NAT on window period reduction and residual risk. J Clin Virol 36(Suppl 1):S23\u2013SS2","journal-title":"J Clin Virol"},{"issue":"3p2","key":"6056_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1423-0410.2009.01272.x","volume":"98","author":"H Scheiblauer","year":"2010","unstructured":"Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhard H, Grunert H-P, Prince A (2010) Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang 98(3p2):403\u2013414","journal-title":"Vox Sang"},{"key":"6056_CR17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00042737-200411000-00021","volume":"16","author":"C-H Chen","year":"2004","unstructured":"Chen C-H, Lee C-M, Wang J-H, Tung H-D, Hung C-H, Lu S-N (2004) Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gast Hepatol 16:1213\u20131218","journal-title":"Eur J Gast Hepatol"},{"key":"6056_CR18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"Y-F Liaw","year":"2009","unstructured":"Liaw Y-F, Chu C-M (2009) Hepatitis B virus infection. Lancet 373:582\u2013592","journal-title":"Lancet"},{"key":"6056_CR19","doi-asserted-by":"publisher","unstructured":"Michitaka K, Hiraoka A, Tokumoto Y, Ninomiya K, Ninomiya T, Horiike N, Abe M, Hiasa Y (2014) Clinical features of adult patients with acute hepatitis B virus infection progressing to chronic infection. Int J Hepatol:358206. https:\/\/doi.org\/10.1155\/2014\/358206","DOI":"10.1155\/2014\/358206"},{"issue":"11","key":"6056_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141741","volume":"10","author":"N Sarkar","year":"2015","unstructured":"Sarkar N, Pal A, Das D, Saha D, Biswas A, Bandopadhayay B, Chakraborti M, Ghosh M, Chakravarty R (2015) Virological characteristics of acute hepatitis B in eastern India: critical differences with chronic infection. PLoS One 10(11):e0141741. https:\/\/doi.org\/10.1371\/journal.pone.0141741 eCollection 2015","journal-title":"PLoS One"},{"issue":"1","key":"6056_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1096-9071(199805)55:1<35::AID-JMV7>3.0.CO;2-P","volume":"55","author":"K Inoue","year":"1998","unstructured":"Inoue K, Yoshiba M, Sekiyama K, Okamoto H, Mayumi M (1998) Clinical and molecular virological differences between fulminant hepatic failures following acute and chronic infection with hepatitis B virus. J Med Virol 55(1):35\u201341","journal-title":"J Med Virol"},{"issue":"7","key":"6056_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006088","volume":"96","author":"X Du","year":"2017","unstructured":"Du X, Liu Y, Ma L et al (2017) Virological and serological features of acute hepatitis B in adults. Medicine (Baltimore) 96(7):e6088. https:\/\/doi.org\/10.1097\/MD.0000000000006088","journal-title":"Medicine (Baltimore)"},{"key":"6056_CR23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","volume":"32","author":"GJ Webster","year":"2000","unstructured":"Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amlot PL, Williams R, Vergani D, Dusheiko GM, Bertoletti A (2000) Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32:1117\u20131124","journal-title":"Hepatology"},{"issue":"1","key":"6056_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/hep.24615","volume":"55","author":"TC Tseng","year":"2012","unstructured":"Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH (2012) Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology 55(1):68\u201376","journal-title":"Hepatology"},{"issue":"3","key":"6056_CR25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/jir283","volume":"204","author":"HL Chan","year":"2011","unstructured":"Chan HL, Wong GL, Tse CH, Chan HY, Wong VW (2011) Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients. J Infect Dis 204(3):408\u2013414","journal-title":"J Infect Dis"},{"issue":"2","key":"6056_CR26","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1073\/pnas.0913498107","volume":"107","author":"PL Yang","year":"2010","unstructured":"Yang PL, Althage A, Chung J, Maier H, Wieland S, Isogawa M, Chisari FV (2010) Immune effectors required for hepatitis B v\u00edrus clearance. Proc Natl Acad Sci U S A 107(2):798\u2013802","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3\u20134","key":"6056_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/HAB-2011-0242","volume":"20","author":"ZA Jeremiah","year":"2011","unstructured":"Jeremiah ZA, Idris H, Ajayi BB, Ezimah AC, Malah MB, Baba MM (2011) Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nig\u00e9ria. Hum Antibodies 20(3\u20134):77\u201382","journal-title":"Hum Antibodies"},{"issue":"4","key":"6056_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10096-012-1781-9","volume":"32","author":"RA Pond\u00e9","year":"2013","unstructured":"Pond\u00e9 RA (2013) Atypical serological profiles in hepatitis B virus infection. Eur J ClinMicrobiol Infect Dis 32(4):461\u2013476. https:\/\/doi.org\/10.1007\/s10096-012-1781-9","journal-title":"Eur J ClinMicrobiol Infect Dis"},{"issue":"4782","key":"6056_CR29","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","volume":"234","author":"DR Milich","year":"1986","unstructured":"Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234(4782):1398\u20131401","journal-title":"Science"},{"key":"6056_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJM200007063430107","volume":"343","author":"P Delves","year":"2000","unstructured":"Delves P, Roitt I (2000) The immune system (first of two parts). N Engl J Med 343:37\u201349","journal-title":"N Engl J Med"},{"key":"6056_CR31","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1172\/JCI116497","volume":"91","author":"T Maruyama","year":"1993","unstructured":"Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR (1993) The serology of chronic hepatitis B infection revisited. J Clin Invest 91:2586\u20132595","journal-title":"J Clin Invest"},{"key":"6056_CR32","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/JVI.69.6.3358-3368.1995","volume":"69","author":"MC Jung","year":"1995","unstructured":"Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, Fr\u00f6sner G, Will H, Pape GR (1995) Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 69:3358\u20133368","journal-title":"J Virol"},{"issue":"4","key":"6056_CR33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.patbio.2009.11.001","volume":"58","author":"F Chisari","year":"2010","unstructured":"Chisari F, Isogawa M, Wieland S (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58(4):258\u2013266","journal-title":"Pathol Biol (Paris)"},{"issue":"6","key":"6056_CR34","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1128\/JCM.00234-06","volume":"44","author":"V Avettand-Fenoel","year":"2006","unstructured":"Avettand-Fenoel V, Thabut D, Katlama C, Poynard T, Thibault V (2006) Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection. J Clin Microbiol 44(6):2250\u20132253","journal-title":"J Clin Microbiol"},{"issue":"1","key":"6056_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2893.2007.00912.x","volume":"14","author":"W Gerlich","year":"2007","unstructured":"Gerlich W, Glebe D, Schuttler C (2007) Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 14(1):16\u201321","journal-title":"J Viral Hepat"},{"key":"6056_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00430-010-0160-3","volume":"200","author":"R Pond\u00e9","year":"2011","unstructured":"Pond\u00e9 R (2011) The underlying mechanisms for the \u201cisolated positivity for the hepatitis B surface antigen (HBsAg)\u201d serological profile. Med Microbiol Immunol 200:13\u201322","journal-title":"Med Microbiol Immunol"},{"key":"6056_CR37","doi-asserted-by":"publisher","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","volume":"4","author":"MF Yuen","year":"2018","unstructured":"Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL (2018) Hepatitis B virus infection. Nat Rev Dis Primers 4:18035. https:\/\/doi.org\/10.1038\/nrdp.2018.35 PMID: 29877316","journal-title":"Nat Rev Dis Primers"},{"key":"6056_CR38","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.22034\/APJCP.2018.19.8.2125","volume":"8","author":"M Makvandi","year":"2018","unstructured":"Makvandi M, Soleimani R, Samarbafzadeh A et al (2018) Natural history of chronic hepatitis B virus infection in Ahvaz City, Iran. Asian Pac J Cancer Prev 8:2125\u20132129. https:\/\/doi.org\/10.22034\/APJCP.2018.19.8.2125","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"6056_CR39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7861\/clinmedicine.15-2-191","volume":"15","author":"US Gill","year":"2015","unstructured":"Gill US, Kennedy PT (2015) New insights in the management of chronic hepatitis B. Clin Med (Lond) 15(2):191\u2013196","journal-title":"Clin Med (Lond)"},{"key":"6056_CR40","first-page":"395","volume":"46","author":"CK Hui","year":"2007","unstructured":"Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L et al (2007) Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology 46:395\u2013401","journal-title":"Hepatology"},{"key":"6056_CR41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00535-017-1315-4","volume":"52","author":"T Tomoko","year":"2017","unstructured":"Tomoko T, Hitoshi T, Satoyo H (2017) Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission. J Gastroenterol 52:1041\u20131050","journal-title":"J Gastroenterol"},{"issue":"11","key":"6056_CR42","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/jmv.24032","volume":"86","author":"G Song","year":"2014","unstructured":"Song G, Rao H, Feng B, Wei L (2014) Prediction of spontaneous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients during the immune clearance phase. J Med Virol 86(11):1838\u20131844. https:\/\/doi.org\/10.1002\/jmv.24032","journal-title":"J Med Virol"},{"issue":"10","key":"6056_CR43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41575-019-0197-8","volume":"16","author":"YF Liaw","year":"2019","unstructured":"Liaw YF (2019) Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection. Nat Rev Gastroenterol Hepatol 16(10):631\u2013641","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6056_CR44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1478-3231.2006.01319.x","volume":"26","author":"CJ Liu","year":"2006","unstructured":"Liu CJ, Chen PJ, Lai MY, Lin FY, Wang T, Kao JH et al (2006) Viral factors correlate with hepatitis B e antigen seroconversion in patients with chronic hepatitis B. Liver Int 26:949\u2013955","journal-title":"Liver Int"},{"key":"6056_CR45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH (2016) AASLD guidelines for treatment of chronic hepatitis B. Hepatology 63:261\u2013283","journal-title":"Hepatology"},{"issue":"2","key":"6056_CR46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3350\/cmh.2017.0068","volume":"24","author":"L-H Wong","year":"2018","unstructured":"Wong L-H (2018) Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend. Clin Mol Hepatol 24(2):108\u2013113","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"6056_CR47","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","volume":"51","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA (2010) Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 51(6):1933\u20131944","journal-title":"Hepatology"},{"key":"6056_CR48","unstructured":"Hwang J. P, Lok A. S (2014) Management of patients with hepatitis B who require immunosuppressive therapy. Nat Rev Gastroenterol Hepatol 11(4):209\u2013219"},{"issue":"Suppl 1","key":"6056_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/liv.13006","volume":"36","author":"F Invernizzi","year":"2016","unstructured":"Invernizzi F, Vigan\u00f2 M, Grossi G, Lampertico P (2016) The prognosis and management of inactive HBV carriers. Liver Int 36(Suppl 1):100\u2013104. https:\/\/doi.org\/10.1111\/liv.13006","journal-title":"Liver Int"},{"issue":"17","key":"6056_CR50","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1001\/jama.2018.3795","volume":"319","author":"LSY Tang","year":"2018","unstructured":"Tang LSY, Covert E, Wilson E, Kottilil S (2018) Chronic hepatitis B infection: a review. JAMA 319(17):1802\u20131813. https:\/\/doi.org\/10.1001\/jama.2018.3795 Erratum in: JAMA. 2018 Sep 18;320(11):1202. PMID: 29715359","journal-title":"JAMA"},{"issue":"2","key":"6056_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jmv.20176","volume":"74","author":"CJ Liu","year":"2004","unstructured":"Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS (2004) Evolution of precore\/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion. J Med Virol 74(2):237\u2013245. https:\/\/doi.org\/10.1002\/jmv.20176","journal-title":"J Med Virol"},{"key":"6056_CR52","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/ajg.2009.187","volume":"104","author":"CM Chu","year":"2009","unstructured":"Chu CM, Liaw YF (2009) Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 104:1693\u20131699","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"6056_CR53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","volume":"45","author":"AS Lok","year":"2007","unstructured":"Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology. 45(2):507\u2013539","journal-title":"Hepatology."},{"key":"6056_CR54","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.amjmed.2003.12.040","volume":"116","author":"CM Chu","year":"2004","unstructured":"Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF (2004) Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 116:829\u2013834","journal-title":"Am J Med"},{"key":"6056_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.gastro.2009.09.018","volume":"138","author":"JF Wu","year":"2010","unstructured":"Wu JF, Wu TC, Chen CH, Ni YH, Chen HL, Hsu HY et al (2010) Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology 138:165\u2013172","journal-title":"Gastroenterology"},{"key":"6056_CR56","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/infdis\/jis420","volume":"206","author":"JF Wu","year":"2012","unstructured":"Wu JF, Chen CH, Ni YH, Lin YT, Chen HL, Hsu HY et al (2012) Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long term prospective cohort study in Taiwan. J Infect Dis 206:662\u2013668","journal-title":"J Infect Dis"},{"key":"6056_CR57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.23348","volume":"51","author":"YC Chen","year":"2010","unstructured":"Chen YC, Chu CM, Liaw YF (2010) Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. Hepatology 51:435\u2013444","journal-title":"Hepatology"},{"key":"6056_CR58","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1053\/j.gastro.2004.09.048","volume":"127","author":"YH Ni","year":"2004","unstructured":"Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH et al (2004) Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 127:1733\u20131738","journal-title":"Gastroenterology"},{"key":"6056_CR59","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","volume":"118","author":"JH Kao","year":"2000","unstructured":"Kao JH, Chen PJ, Lai MY, Chen DS (2000) Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554\u2013559","journal-title":"Gastroenterology"},{"key":"6056_CR60","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2007.08.010","volume":"133","author":"SE Livingston","year":"2007","unstructured":"Livingston SE, Simonetti JP, Bulkow LR, Homan CE, Snowball MM, Cagle HH, Negus SE et al (2007) Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes a, B, C, D, and F. Gastroenterology 133:1452\u20131457","journal-title":"Gastroenterology"},{"key":"6056_CR61","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cgh.2008.08.021","volume":"6","author":"EB Keeffe","year":"2008","unstructured":"Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER et al (2008) A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 6:1315\u20131341","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6056_CR62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","volume":"136","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Gane E, Leung N et al (2009) 2-year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology 136:486\u2013495","journal-title":"Gastroenterology"},{"key":"6056_CR63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","volume":"365","author":"HL Janssen","year":"2005","unstructured":"Janssen HL, van Zonneveld M, Senturk H et al (2005) Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet. 365:123\u2013129","journal-title":"Lancet."},{"issue":"3","key":"6056_CR64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bjid.2017.03.001","volume":"21","author":"W Yu","year":"2017","unstructured":"Yu W, Wang Y, Shen C, Ji R, Zhang L, Zhao X, Su M, Zhang Y, He W, Cao J, Hao Y, Chen S, Zhao C (2017) Predictors of HBeAg seroconversion after long-term nucleos(t) ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting. Braz J Infec tDis 21(3):213\u2013218","journal-title":"Braz J Infec tDis"},{"issue":"6","key":"6056_CR65","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","volume":"51","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, Lau GK, Lewin SR, Visvanathan K, Desmond PV, Locarnini SA (2010) Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B v\u00edrus markers. Hepatology 51(6):1933\u20131944","journal-title":"Hepatology"},{"key":"6056_CR66","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351:1521\u20131531","journal-title":"N Engl J Med"},{"issue":"41","key":"6056_CR67","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.3748\/wjg.v12.i41.6693","volume":"12","author":"JW Shin","year":"2006","unstructured":"Shin JW, Park NH, Jung SW, Kim BC, Kwon SH, Park JS, Jeong I, Bang S-J, Kim DH (2006) Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive. World J Gastroenterol 12(41):6693\u20136698","journal-title":"World J Gastroenterol"},{"issue":"2","key":"6056_CR68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1872-034X.2009.00565.x","volume":"40","author":"M Kobayashi","year":"2010","unstructured":"Kobayashi M, Suzuki F, Akuta N, Yatsuji H, Hosaka T, Sezaki H, Kobayashi M, Kawamura Y, Suzuki Y, Arase Y, Ikeda K, Mineta R, Iwasaki S, Watahiki S, Kumada H (2010) Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment. Hepatol Res 40(2):125\u2013134. https:\/\/doi.org\/10.1111\/j.1872-034X.2009.00565.x","journal-title":"Hepatol Res"},{"key":"6056_CR69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-981-13-9151-4_6","volume":"1179","author":"Y Tao","year":"2020","unstructured":"Tao Y, Wu D, Zhou L, Chen E, Liu C, Tang X, Jiang W, Han N, Li H, Tang H (2020) Present and future therapies for chronic hepatitis B. Adv Exp Med Biol 1179:137\u2013186","journal-title":"Adv Exp Med Biol"},{"key":"6056_CR70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","volume":"6","author":"YF Liaw","year":"2012","unstructured":"Liaw YF, Kao JH, Piratvisuth T et al (2012) Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 6:531\u2013561","journal-title":"Hepatol Int"},{"key":"6056_CR71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","volume":"50","author":"EASL Clinical Practice Guidelines","year":"2009","unstructured":"Clinical Practice Guidelines EASL (2009) Management of chronic hepatitis B. J Hepatol 50:227\u2013242","journal-title":"J Hepatol"},{"issue":"6","key":"6056_CR72","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000086061","volume":"48","author":"SK Yoon","year":"2005","unstructured":"Yoon SK, Jang JW, Kim CW, Bae SH, Choi JY, Choi SW, Lee YS, Lee CD, Chung KW, Sun HS, Kim BS (2005) Long-term results of lamivudine monotherapy in Korean patients with HBeAg-positive chronic hepatitis B: response and relapse rates, and factors related to durability of HBeAg seroconversion. Intervirology. 48(6):341\u2013349","journal-title":"Intervirology."},{"issue":"2","key":"6056_CR73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.gastro.2010.03.059","volume":"139","author":"JG Reijnders","year":"2010","unstructured":"Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL (2010) Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B. Gastroenterology 139(2):491\u2013498","journal-title":"Gastroenterology"},{"issue":"43","key":"6056_CR74","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.3748\/wjg.v18.i43.6277","volume":"18","author":"MJ Song","year":"2012","unstructured":"Song MJ, Song DS, Kim HY, Yoo SH, Bae SH, Choi JY, Yoon SK, Paik Y-H, Lee JS, Lee WH, Kim HJ (2012) Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B. World J Gastroenterol 18(43):6277\u20136283","journal-title":"World J Gastroenterol"},{"issue":"1 Suppl","key":"6056_CR75","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","volume":"64","author":"S Tong","year":"2016","unstructured":"Tong S, Revill P (2016) Overview of hepatitis B viral replication and genetic variability. J Hepatol 64(1 Suppl):S4\u2013S16. https:\/\/doi.org\/10.1016\/j.jhep.2016.01.027","journal-title":"J Hepatol"},{"issue":"2","key":"6056_CR76","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3748\/wjg.v21.i2.541","volume":"21","author":"N Kamijo","year":"2015","unstructured":"Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E (2015) Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion. World J Gastroenterol 21(2):541\u2013548","journal-title":"World J Gastroenterol"},{"key":"6056_CR77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000074988","volume":"46","author":"Y Miyakawa","year":"2003","unstructured":"Miyakawa Y, Mizokami M (2003) Classifying hepatitis B virus genotypes. Intervirol 46:329\u2013338","journal-title":"Intervirol"},{"issue":"3","key":"6056_CR78","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2014.04.033","volume":"61","author":"T Inuzuka","year":"2014","unstructured":"Inuzuka T, Ueda Y, Morimura H, Fujii Y, Umeda M, Kou T, Osaki Y, Uemoto S, Chiba T, Marusawa H (2014) Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence. J Hepatol 61(3):492\u2013501","journal-title":"J Hepatol"},{"issue":"4","key":"6056_CR79","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12072-014-9554-4","volume":"8","author":"G Yang","year":"2014","unstructured":"Yang G, Han M, Chen F, Xu Y, Chen E, Wang X, Liu Y, Sun J, Hou J, Ning Q, Wang Z (2014) Hepatitis B virus genotype B and mutations in basal core promoter and pre-core\/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China. Hepatol Int 8(4):508\u2013516","journal-title":"Hepatol Int"},{"key":"6056_CR80","volume":"7","author":"DW Kim","year":"2012","unstructured":"Kim DW, Lee SA, Hwang ES, Kook YH, Kim BJ (2012) Naturally occurring precore\/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma. PLoS One 7:e47372","journal-title":"PLoS One"},{"issue":"17","key":"6056_CR81","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3748\/wjg.v22.i17.4287","volume":"22","author":"H Kim","year":"2016","unstructured":"Kim H, Lee SA, Do SY, Kim BJ (2016) Precore\/core region mutations of hepatitis B virus related to clinical severity. World J Gastroenterol 22(17):4287\u20134296","journal-title":"World J Gastroenterol"},{"issue":"11","key":"6056_CR82","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.3748\/wjg.v22.i11.3268","volume":"22","author":"XL Wang","year":"2016","unstructured":"Wang XL, Ren JP, Wang XQ, Wang XH, Yang SF, Xiong Y (2016) Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients. World J Gastroenterol 22(11):3268\u20133274","journal-title":"World J Gastroenterol"},{"issue":"6","key":"6056_CR83","volume":"7","author":"A Malik","year":"2012","unstructured":"Malik A, Singhal DK, Albanyan A, Husain SA, Kar P (2012) Hepatitis B virus gene mutations in liver diseases: a report from New Delhi. PLoS One 7(6):e39028","journal-title":"PLoS One"},{"issue":"11","key":"6056_CR84","doi-asserted-by":"publisher","first-page":"12525","DOI":"10.18632\/oncotarget.7123","volume":"15;7","author":"Z Yang","year":"2016","unstructured":"Yang Z, Zhuang L, Lu Y, Xu Q, Tang B, Chen X (2016) Naturally occurring basal core promoter A1762T\/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis. Oncotarget 15;7(11):12525\u201312536. https:\/\/doi.org\/10.18632\/oncotarget.7123","journal-title":"Oncotarget"},{"issue":"16","key":"6056_CR85","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1128\/JVI.78.16.8524-8535.2004","volume":"78","author":"F Tacke","year":"2004","unstructured":"Tacke F, Gehrke C, LueddTe HA, Manns M, Trautwein C (2004) Basal Core promoter and Precore mutations in the hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants. J Virol 78(16):8524\u20138535","journal-title":"J Virol"},{"issue":"24","key":"6056_CR86","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.3748\/wjg.v20.i24.7644","volume":"20","author":"A Alexopoulou","year":"2014","unstructured":"Alexopoulou A, Karayiannis P (2014) HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection. World J Gastroenterol 20(24):7644\u20137652. https:\/\/doi.org\/10.3748\/wjg.v20.i24.7644","journal-title":"World J Gastroenterol"},{"key":"6056_CR87","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jmv.24064","volume":"87","author":"A Pivert","year":"2015","unstructured":"Pivert A, Servant-Delmas A, Lunel-Fabiani F, Le Guillou-Guillemette H, Laperche S, Ducancelle A (2015) Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus. J Med Virol 87:529\u2013535","journal-title":"J Med Virol"},{"issue":"2","key":"6056_CR88","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/s-2006-939754","volume":"26","author":"TJ Harrison","year":"2006","unstructured":"Harrison TJ (2006) Hepatitis B virus: molecular virology and common mutants. Semin Liver Dis 26(2):87\u201396. https:\/\/doi.org\/10.1055\/s-2006-939754 Erratum in: Semin Liver Dis 26(3):304-5. PMID: 16673287","journal-title":"Semin Liver Dis"},{"issue":"1","key":"6056_CR89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3748\/wjg.v22.i1.145","volume":"22","author":"P Caligiuri","year":"2016","unstructured":"Caligiuri P, Cerruti R, Icardi G, Bruzzone B (2016) Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 22(1):145\u2013154. https:\/\/doi.org\/10.3748\/wjg.v22.i1.145","journal-title":"World J Gastroenterol"},{"key":"6056_CR90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12985-015-0313-5","volume":"11;12","author":"F Hu","year":"2015","unstructured":"Hu F, Bi S, Yan H, Shi Y, Sheng J (2015) Associations between hepatitis B virus basal core promoter\/pre-core region mutations and the risk of acute-on-chronic liver failure: a meta-analysis. Virol J 11;12:87","journal-title":"Virol J"},{"issue":"4","key":"6056_CR91","doi-asserted-by":"publisher","first-page":"379.e1","DOI":"10.1016\/j.cmi.2015.10.033","volume":"22","author":"YW Zhong","year":"2016","unstructured":"Zhong YW, Di FL, Liu C, Zhang XC, Bi JF, Li YL, Wu SQ, Dong H, Liu LM, He J, Shi YM, Zhang HF, Zhang M (2016) Hepatitis B virus basal core promoter\/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection. Clin Microbiol Infect 22(4):379.e1\u2013379.e8. https:\/\/doi.org\/10.1016\/j.cmi.2015.10.033","journal-title":"Clin Microbiol Infect"},{"key":"6056_CR92","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1471-2334-10-271","volume":"16;10","author":"D Zhang","year":"2010","unstructured":"Zhang D, Ma S, Zhang X, Zhao H, Ding H, Zeng C (2010) Prevalent HBV point mutations and mutation combinations at BCP\/preC region and their association with liver disease progression. BMC Infect Dis 16;10:271. https:\/\/doi.org\/10.1186\/1471-2334-10-271","journal-title":"BMC Infect Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-06056-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T17:02:50Z","timestamp":1613667770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-06056-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["6056"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-06056-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"17 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that there are no competing interests (financial or non-financial) related to the content of the specific article. The author further states that this paper comprises a review article and that, for its compilation, it did not require research involving human participants and\/or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}